FIELD: chemistry.
SUBSTANCE: invention relates to compounds of the formula .
EFFECT: technical result: new compounds have been obtained, which are the SYK inhibitors and are useful for the treatment of autoimmune and inflammatory diseases.
9 cl, 2 tbl, 38 ex
Title | Year | Author | Number |
---|---|---|---|
JAK INHIBITORS | 2010 |
|
RU2538204C2 |
COMPOUNDS OF PYRIDAZINAMIDE AND THEIR USE AS SYNTHETIC SYNECKINASIS INHIBITORS (SYK) | 2013 |
|
RU2627661C2 |
PHARMACEUTICAL COMPOUNDS | 2019 |
|
RU2821941C2 |
DERIVATIVE 6-CARBONITRILE DIPYRIDOPYRROLES AND APPLICATION THEREOF IN CANCER TREATMENT | 2010 |
|
RU2575635C2 |
SUBSTITUTED PYRROLES ACTIVE AS KINASES INHIBITORS | 2013 |
|
RU2666538C2 |
IMIDAZOPYRIDAZINES | 2012 |
|
RU2662443C2 |
JAK INHIBITOR COMPOUND AND USE THEREOF | 2020 |
|
RU2820445C2 |
PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
PHARMACEUTICAL AGENT CONTAINING INHIBITOR OF SODIUM-DEPENDENT PHOSPHATE CARRIER | 2015 |
|
RU2740008C2 |
THIAZOLOPYRIMIDINONES AS MODULATORS OF NMDA RECEPTOR ACTIVITY | 2014 |
|
RU2703273C2 |
Authors
Dates
2018-06-07—Published
2013-08-19—Filed